Thrombolysis in STEMI in the era of COVID – Holding fort in cardiologist deficit locales

During the COVID-19 pandemic, the pharmaco-invasive approach in the management of ST Elevation Myocardial Infarction (STEMI) played a vital role in saving many lives. A retrospective observational study was conducted wherein 134 patients presenting with STEMI between (Dec 2019–Mar 2022) were thrombo...

Descripción completa

Detalles Bibliográficos
Autores principales: Karanth, Jnanaprakash B., Ramamoorthy, Ananthakrishnan, Maribashetti, Kiran, Ramanan, Ezhil Arasan, Ravi, Sailatha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Brief
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172153/
https://www.ncbi.nlm.nih.gov/pubmed/37178868
http://dx.doi.org/10.1016/j.ihj.2023.05.002
Descripción
Sumario:During the COVID-19 pandemic, the pharmaco-invasive approach in the management of ST Elevation Myocardial Infarction (STEMI) played a vital role in saving many lives. A retrospective observational study was conducted wherein 134 patients presenting with STEMI between (Dec 2019–Mar 2022) were thrombolysed with either streptokinase or tenecteplase in a centre where primary PCI was not available. There was no significant difference in the outcomes and their predictors between the SK and TNK groups. A prospective study with a larger sample size in the Indian population will be able to provide more substantial and promising results for further interventions.

Ejemplares similares